$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

$fcuv Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000168316822007765 Filed on November 15, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$71.16K	$60.65K	$174.5K
YoY Change	-59.23%	-90.44%	-55.23%
Cost Of Revenue	$87.90K	$42.44K	$114.4K
YoY Change	-23.15%	-91.86%	-68.19%
Gross Profit	-$16.74K	$18.21K	$60.15K
YoY Change	-127.83%	-83.98%	99.04%
Gross Profit Margin	-23.52%	30.03%	34.46%
Selling, General & Admin	$845.5K	$674.1K	$841.7K
YoY Change	0.45%	103.98%	48.74%
% of Gross Profit		3701.35%	1399.25%
Research & Development	$198.2K	$133.1K	$54.57K
YoY Change	263.15%	139.73%	-9.05%
% of Gross Profit		730.85%	90.72%
Depreciation & Amortization	$42.36K	$41.85K	$40.23K
YoY Change	5.29%	1.92%	-0.81%
% of Gross Profit		229.78%	66.88%
Operating Expenses	$1.086M	$992.2K	$936.5K
YoY Change	15.94%	13.88%	49.05%
Operating Profit	-$1.102M	-$974.0K	-$876.3K
YoY Change	25.81%	28.57%	46.53%
Interest Expense	$1.000K	-$28.85K	-$780.00
YoY Change	-228.21%	-96.15%	-65.02%
% of Operating Profit
Other Income/Expense, Net	-$111.8K	$31.95K	$45.86K
YoY Change	-343.72%	-105.51%	-10.95%
Pretax Income	-$1.055M	-$942.0K	-$720.6K
YoY Change	46.37%	-29.58%	31.3%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.055M	-$942.0K	-$720.6K
YoY Change	46.37%	-29.58%	31.3%
Net Earnings / Revenue	-1482.14%	-1553.1%	-412.86%
Basic Earnings Per Share		-$0.02
Diluted Earnings Per Share	-$0.02	-$0.02	-$19.43K
COMMON SHARES
Basic Shares Outstanding	43.53M shares	43.42M shares	43.26M shares
Diluted Shares Outstanding		43.46M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.449M	$6.147M	$8.679M
YoY Change	-48.74%	-35.53%	1387.78%
Cash & Equivalents	$4.343M	$6.062M	$8.679M
Short-Term Investments	$105.5K	$84.82K	$0.00
Other Short-Term Assets	$142.3K	$183.6K	$307.2K
YoY Change	-53.67%	20.41%	60.65%
Inventory	$103.8K	$49.11K	$22.89K
Prepaid Expenses	$142.3K	$183.6K	$301.3K
Receivables	$78.31K	$137.5K	$177.3K
Other Receivables	$0.00	$13.06K	$13.06K
Total Short-Term Assets	$4.808M	$6.591M	$9.214M
YoY Change	-47.82%	-34.16%	814.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.229M	$4.267M	$4.353M
YoY Change	-2.86%	-2.53%	-3.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$33.26K	$34.30K	$33.93K
YoY Change	-1.97%	5096.97%	411.76%
Total Long-Term Assets	$4.515M	$4.468M	$4.807M
YoY Change	-6.08%	0.9%	4.83%
TOTAL ASSETS
Total Short-Term Assets	$4.808M	$6.591M	$9.214M
Total Long-Term Assets	$4.515M	$4.468M	$4.807M
Total Assets	$9.323M	$11.06M	$14.02M
YoY Change	-33.51%	-23.41%	150.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$267.7K	$168.6K	$0.00
YoY Change			-100.0%
Accrued Expenses	$113.1K	$103.3K	$121.6K
YoY Change	-7.0%	85.76%	127.74%
Deferred Revenue			$271.00
YoY Change			-99.53%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$132.6K
YoY Change	-100.0%	-100.0%	-31.68%
Total Short-Term Liabilities	$1.387M	$2.278M	$571.4K
YoY Change	142.76%	261.94%	8.32%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$25.93K
YoY Change	-100.0%	-100.0%	-87.21%
Other Long-Term Liabilities	$12.34K	$12.34K	$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$178.3K	$202.1K	$328.3K
YoY Change	-45.7%	127.95%	25.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.387M	$2.278M	$571.4K
Total Long-Term Liabilities	$178.3K	$202.1K	$328.3K
Total Liabilities	$1.566M	$2.481M	$899.8K
YoY Change	73.99%	245.4%	14.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.86M	-$16.81M	-$12.94M
YoY Change	38.08%	37.6%	33.15%
Common Stock	$43.53K	$43.53K	$43.26K
YoY Change	0.63%	0.62%	5.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.000M	$400.00	$0.00
YoY Change
Treasury Stock Shares		400.0K shares	400.0K shares
Shareholders Equity	$7.758M	$8.579M	$13.12M
YoY Change
Total Liabilities & Shareholders Equity	$9.323M	$11.06M	$14.02M
YoY Change	-33.51%	-23.41%	150.69%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	-$1.055M	-$942.0K	-$720.6K
YoY Change	46.37%	-29.58%	31.3%
Depreciation, Depletion And Amortization	$42.36K	$41.85K	$40.23K
YoY Change	5.29%	1.92%	-0.81%
Cash From Operating Activities	-$522.8K	-$685.7K	-$731.6K
YoY Change	-28.54%	28.76%	218.67%
INVESTING ACTIVITIES
Capital Expenditures	$3.000K	$510.00	-$16.11K
YoY Change	-118.62%	-107.41%
Acquisitions
YoY Change
Other Investing Activities	-$30.52K	$89.29K
YoY Change
Cash From Investing Activities	-$33.52K	$89.80K	-$16.11K
YoY Change	108.07%	-1405.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.159M	0.000	-108.7K
YoY Change	965.33%	-100.0%	1108.33%
NET CHANGE
Cash From Operating Activities	-522.8K	-685.7K	-731.6K
Cash From Investing Activities	-33.52K	89.80K	-16.11K
Cash From Financing Activities	-1.159M	0.000	-108.7K
Net Change In Cash	-1.715M	-595.9K	-856.5K
YoY Change	100.23%	-107.31%	258.98%
FREE CASH FLOW
Cash From Operating Activities	-$522.8K	-$685.7K	-$731.6K
Capital Expenditures	$3.000K	$510.00	-$16.11K
Free Cash Flow	-$525.8K	-$686.2K	-$715.5K
YoY Change	-26.51%	30.54%	211.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	us-gaap	Inventory Net InventoryNet	49109	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	22889	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001590418
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities		usd
CY2022Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent		usd
CY2021Q4	FCUV	Treasurys Stock Payable TreasurysStockPayable		usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
	FCUV	Shares Issued For Cashless Exercise Of Warrants Value SharesIssuedForCashlessExerciseOfWarrantsValue		usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55247
	dei	Entity Registrant Name EntityRegistrantName	FOCUS UNIVERSAL INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3355876
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2311 E. Locust Court
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ontario
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91761
	dei	City Area Code CityAreaCode	(626)
	dei	Local Phone Number LocalPhoneNumber	272-3883
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	FCUV
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43528915	shares
CY2022Q3	us-gaap	Cash Cash	6062418	usd
CY2021Q4	us-gaap	Cash Cash	8678665	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	137464	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	177315	usd
CY2022Q3	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	60589	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	15176	usd
CY2022Q3	us-gaap	Other Receivables OtherReceivables	13057	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	13057	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	183620	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	301270	usd
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	84815	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	5968	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	6591072	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9214340	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4266907	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4353340	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167122	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	420137	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	34296	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	33933	usd
CY2022Q3	us-gaap	Assets Assets	11059397	usd
CY2021Q4	us-gaap	Assets Assets	14021750	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	168600	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	293354	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6496	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	23902	usd
CY2022Q3	FCUV	Treasurys Stock Payable TreasurysStockPayable	2000000	usd
CY2022Q3	us-gaap	Loans Payable Current LoansPayableCurrent	0	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	132618	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	103344	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	121568	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2278440	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	571442	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	189759	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	302387	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	25929	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12335	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	202094	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	328316	usd
CY2022Q3	us-gaap	Liabilities Liabilities	2480534	usd
CY2021Q4	us-gaap	Liabilities Liabilities	899758	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43528915	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43528915	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43259741	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43259741	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	43529	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	43259	usd
CY2022Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	400000	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	400000	shares
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	400	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	-0	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25319339	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24093075	usd
CY2022Q3	FCUV	Shares To Be Issued Common Share SharesToBeIssuedCommonShare	21020	usd
CY2021Q4	FCUV	Shares To Be Issued Common Share SharesToBeIssuedCommonShare	1922753	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16809338	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12937091	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4713	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	8578863	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13121992	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11059397	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14021750	usd
CY2022Q3	us-gaap	Revenues Revenues	60654	usd
CY2021Q3	us-gaap	Revenues Revenues	634777	usd
	us-gaap	Revenues Revenues	282463	usd
	us-gaap	Revenues Revenues	1259920	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	42441	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	521334	usd
	us-gaap	Cost Of Revenue CostOfRevenue	243004	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1022666	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	18213	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	113443	usd
	us-gaap	Gross Profit GrossProfit	39459	usd
	us-gaap	Gross Profit GrossProfit	237254	usd
CY2022Q3	us-gaap	Selling Expense SellingExpense	76984	usd
CY2021Q3	us-gaap	Selling Expense SellingExpense	14776	usd
	us-gaap	Selling Expense SellingExpense	132871	usd
	us-gaap	Selling Expense SellingExpense	15734	usd
CY2022Q3	us-gaap	Officers Compensation OfficersCompensation	34000	usd
CY2021Q3	us-gaap	Officers Compensation OfficersCompensation	34600	usd
	us-gaap	Officers Compensation OfficersCompensation	144040	usd
	us-gaap	Officers Compensation OfficersCompensation	107700	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	133109	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55525	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	862214	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	165897	usd
CY2022Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	150943	usd
CY2021Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	343787	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	686150	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	801262	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	597143	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	422309	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2317359	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1286943	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	992179	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	870997	usd
	us-gaap	Operating Expenses OperatingExpenses	4142634	usd
	us-gaap	Operating Expenses OperatingExpenses	2377536	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-973966	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-757554	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4103175	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2140282	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2635	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-14069	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2885	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-36825	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	107460	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	260450	usd
CY2022Q3	FCUV	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	0	usd
CY2021Q3	FCUV	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-1284780	usd
	FCUV	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	0	usd
	FCUV	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-1284780	usd
CY2022Q3	FCUV	Gain On Settlement Of Derivative Liability GainOnSettlementOfDerivativeLiability	0	usd
CY2021Q3	FCUV	Gain On Settlement Of Derivative Liability GainOnSettlementOfDerivativeLiability	550406	usd
	FCUV	Gain On Settlement Of Derivative Liability GainOnSettlementOfDerivativeLiability	0	usd
	FCUV	Gain On Settlement Of Derivative Liability GainOnSettlementOfDerivativeLiability	550406	usd
CY2022Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	42101	usd
CY2021Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-32525	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2022Q3	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-31486	usd
CY2021Q3	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-21205	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18696	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	60783	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	281773	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	150616	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	31946	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-580200	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	230928	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-360133	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-942020	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1337754	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3872247	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2500415	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-942020	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1337754	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3872247	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2500415	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-4596	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-0	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-4717	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-0	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-937424	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1337754	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3867530	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2500415	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43462436	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43462436	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43259741	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43259741	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43373708	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43373708	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43259741	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43259741	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	11341556	usd
CY2022Q3	FCUV	Stock Based Compensation Options StockBasedCompensationOptions	195751	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-21020	usd
CY2022Q3	FCUV	Purchase Of Treasury Stock PurchaseOfTreasuryStock	-2000000	usd
CY2022Q3	FCUV	Other Comprehensive Loss OtherComprehensiveLoss	4596	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-942020	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	8578863	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	3879626	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11060505	usd
CY2021Q3	FCUV	Stock Based Compensation Options StockBasedCompensationOptions	106837	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	12000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1337754	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	13721214	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13121992	usd
	FCUV	Stock Based Compensation Options StockBasedCompensationOptions	652500	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	663900	usd
	FCUV	Purchase Of Treasury Stock PurchaseOfTreasuryStock	-2000000	usd
	FCUV	Stock Issued During Period Value Issued For Services1 StockIssuedDuringPeriodValueIssuedForServices1	8000	usd
	FCUV	Other Comprehensive Loss OtherComprehensiveLoss	4717	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3872247	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	8578863	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	4804612	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11060505	usd
	FCUV	Stock Based Compensation Options StockBasedCompensationOptions	320512	usd
	FCUV	Common Stock To Be Issued For Services CommonStockToBeIssuedForServices	36000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2500415	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	13721214	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3872247	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2500415	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	72108	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7794	usd
	FCUV	Inventory Fair Value Adjustments InventoryFairValueAdjustments	21133	usd
	FCUV	Inventory Fair Value Adjustments InventoryFairValueAdjustments	-1689	usd
	us-gaap	Depreciation Depreciation	123908	usd
	us-gaap	Depreciation Depreciation	121932	usd
	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-32525	usd
	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-0	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-21205	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-0	usd
	FCUV	Gain Losses On Extinguishment Of Debt GainLossesOnExtinguishmentOfDebt	158547	usd
	FCUV	Gain Losses On Extinguishment Of Debt GainLossesOnExtinguishmentOfDebt	258960	usd
	FCUV	Changes In Fair Value Of Warrant Liability ChangesInFairValueOfWarrantLiability	-0	usd
	FCUV	Changes In Fair Value Of Warrant Liability ChangesInFairValueOfWarrantLiability	-1284780	usd
	FCUV	Gain On Settlement Of Derivative Liability GainOnSettlementOfDerivativeLiability	-0	usd
	FCUV	Gain On Settlement Of Derivative Liability GainOnSettlementOfDerivativeLiability	550406	usd
	FCUV	Share Based Compensation Shares ShareBasedCompensationShares	671901	usd
	FCUV	Share Based Compensation Shares ShareBasedCompensationShares	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	36000	usd
	FCUV	Share Based Compensation Options ShareBasedCompensationOptions	652500	usd
	FCUV	Share Based Compensation Options ShareBasedCompensationOptions	320512	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32257	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	120503	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	45413	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-0	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5087	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-20969	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-116648	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	55280	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-1998	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-100000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	226468	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	36059	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-120121	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	172474	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-17471	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-17135	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	17299	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-271	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-57106	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-94542	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-39044	usd
	FCUV	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	12335	usd
	FCUV	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	-17135	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2435157	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1496812	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39193	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6875	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	768949	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	630404	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-177738	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6875	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	0	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	267297	usd
	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	-0	usd
	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	137900	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	1500000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	-0	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	1500000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	10326131	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10455528	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3352	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2616247	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8951841	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8678665	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	583325	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6062418	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9535166	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	8794	usd
	us-gaap	Interest Paid Net InterestPaidNet	42968	usd
	FCUV	Treasury Stock Payable TreasuryStockPayable	2000000	usd
	FCUV	Treasury Stock Payable TreasuryStockPayable	0	usd
	FCUV	Cashless Warrant CashlessWarrant	0	usd
	FCUV	Cashless Warrant CashlessWarrant	1776044	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3872247	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2435157	usd
	FCUV	Projected Annual Burn Rate ProjectedAnnualBurnRate	3152618	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_z3qBJGtFRAgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_865_ztiAW1rWYXC8">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the accompanying unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include the lease term impacting right-of use asset and lease liability, useful lives of property and equipment, useful lives of intangible assets, allowance for doubtful accounts, inventory reserves, debt discounts, valuation of derivatives, and the valuation allowance on deferred tax assets. The Company regularly evaluates its estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>
CY2022Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	5032437	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	7464846	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	158743	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	86635	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zbPljtNcniy5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_861_zZa31O4ouAaf">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company limits its exposure to credit loss by investing its cash with high credit quality financial institutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	47807	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	68940	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	25929	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	288	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	22827	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	305041	shares
CY2022Q3	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	84815	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167122	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	420137	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	103344	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	121568	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	189759	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	302387	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	288750	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zmp4EmAB4n49" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_z6JCKnJrSE0l">Reclassification</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain reclassifications have been made to the unaudited condensed consolidated financial statements for prior years to the current year’s presentation. Such reclassifications have no effect on net income as previously reported.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	280311	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	48885	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	269174	shares
CY2022Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	12902	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	12470	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	36207	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10419	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	49109	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	22889	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	132618	usd
	FCUV	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P2Y5M1D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4898223	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4860948	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	631316	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	507608	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4266907	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4353340	usd
	us-gaap	Depreciation Depreciation	123908	usd
	us-gaap	Depreciation Depreciation	121932	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	29577	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	131865	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	146653	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	24648	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	332743	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	39640	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	293103	usd
CY2022Q3	us-gaap	Other Loans Payable OtherLoansPayable	0	usd
CY2021Q4	us-gaap	Other Loans Payable OtherLoansPayable	158547	usd
CY2022Q3	us-gaap	Loans Payable Current LoansPayableCurrent	-0	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	121149	shares
CY2022Q2	FCUV	Warrant Exercised WarrantExercised	6.25
CY2022Q2	FCUV	Cashless Exercise Option Of Warrants CashlessExerciseOptionOfWarrants	1776044	usd
CY2021	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	2300000	shares
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	5.00
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43259741	shares
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1041670	usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2326450	usd
CY2021Q4	FCUV	Value Of Shares To Be Issued ValueOfSharesToBeIssued	1284780	usd

Files In Submission

Name	View Source	Status
0001683168-22-007765-index-headers.html	Edgar Link	pending
0001683168-22-007765-index.html	Edgar Link	pending
0001683168-22-007765.txt	Edgar Link	pending
0001683168-22-007765-xbrl.zip	Edgar Link	pending
fcuv-20220930.xsd	Edgar Link	pending
fcuv_ex3101.htm	Edgar Link	pending
fcuv_ex3102.htm	Edgar Link	pending
fcuv_ex3201.htm	Edgar Link	pending
fcuv_ex3202.htm	Edgar Link	pending
fcuv_i10q-093022.htm	Edgar Link	pending
fcuv-20220930_cal.xml	Edgar Link	unprocessable
fcuv-20220930_lab.xml	Edgar Link	unprocessable
fcuv-20220930_def.xml	Edgar Link	unprocessable
fcuv-20220930_pre.xml	Edgar Link	unprocessable
fcuv_i10q-093022_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

2022 Q4 Form 10-Q Financial Statement

#000168316822007765 Filed on November 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV FOCUS UNIVERSAL INC. Stock $fcuv

2022 Q4 Form 10-Q Financial Statement

#000168316822007765 Filed on November 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv